TITLE:
Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)

CONDITION:
Asthma

INTERVENTION:
montelukast sodium

SUMMARY:

      The purpose of this study is to evaluate improved results of treatment for patients entering
      an emergency department with asthma attacks when given an investigational IV administration
      of an approved drug (MK-0476, montelukast sodium) in addition to approved standard
      treatment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 15 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Individuals with acute asthma

        Exclusion Criteria:

          -  Women of child bearing age

          -  History of Chronic Obstructive Pulmonary Disease (COPD)
      
